CA2524092A1 - Composition et utilisation de l'iode pur dissout dans l'huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia - Google Patents

Composition et utilisation de l'iode pur dissout dans l'huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia Download PDF

Info

Publication number: CA2524092A1
Authority: CA; Canada
Prior art keywords: grams; melaleuca; composition; iodine; milliliters
Prior art date: 2003-04-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002524092A

Other languages

English (en)

French (fr)

Inventor

Denis Mbonimpa

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

M K M S C R L

Original Assignee

Mkm Scrl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-28

Filing date

2004-04-28

Publication date

2004-11-11

2004-04-28 Application filed by Mkm Scrl filed Critical Mkm Scrl

2004-11-11 Publication of CA2524092A1 publication Critical patent/CA2524092A1/fr

Status Abandoned legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 46
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 title claims abstract description 42
229910052740 iodine Inorganic materials 0.000 title claims abstract description 42
239000011630 iodine Substances 0.000 title claims abstract description 42
241000366182 Melaleuca alternifolia Species 0.000 title claims abstract description 20
239000000341 volatile oil Substances 0.000 title claims abstract description 10
241000378544 Melaleuca quinquenervia Species 0.000 title claims abstract description 6
201000004946 genital herpes Diseases 0.000 claims abstract description 16
208000001688 Herpes Genitalis Diseases 0.000 claims abstract description 14
238000011282 treatment Methods 0.000 claims abstract description 12
235000009024 Ceanothus sanguineus Nutrition 0.000 claims abstract description 7
235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 7
239000007787 solid Substances 0.000 claims abstract description 6
238000004090 dissolution Methods 0.000 claims abstract description 4
238000004519 manufacturing process Methods 0.000 claims abstract description 4
HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 20
241000378467 Melaleuca Species 0.000 claims description 18
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 14
238000009472 formulation Methods 0.000 claims description 14
244000144725 Amygdalus communis Species 0.000 claims description 11
235000011437 Amygdalus communis Nutrition 0.000 claims description 11
239000008168 almond oil Substances 0.000 claims description 11
239000004327 boric acid Substances 0.000 claims description 11
241000209140 Triticum Species 0.000 claims description 9
235000021307 Triticum Nutrition 0.000 claims description 9
235000011187 glycerol Nutrition 0.000 claims description 9
239000000126 substance Substances 0.000 claims description 9
229920002125 Sokalan® Polymers 0.000 claims description 8
239000003921 oil Substances 0.000 claims description 8
235000019198 oils Nutrition 0.000 claims description 8
206010067152 Oral herpes Diseases 0.000 claims description 7
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 7
230000001225 therapeutic effect Effects 0.000 claims description 7
208000004898 Herpes Labialis Diseases 0.000 claims description 6
239000000839 emulsion Substances 0.000 claims description 6
238000000034 method Methods 0.000 claims description 6
229960001631 carbomer Drugs 0.000 claims description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
239000004480 active ingredient Substances 0.000 claims description 4
230000000844 anti-bacterial effect Effects 0.000 claims description 4
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 4
210000004392 genitalia Anatomy 0.000 claims description 4
239000007788 liquid Substances 0.000 claims description 4
239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 4
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 4
229960002216 methylparaben Drugs 0.000 claims description 4
239000003755 preservative agent Substances 0.000 claims description 4
239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 4
235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 4
239000010497 wheat germ oil Substances 0.000 claims description 4
239000002253 acid Substances 0.000 claims description 3
239000013543 active substance Substances 0.000 claims description 3
230000000855 fungicidal effect Effects 0.000 claims description 3
239000000417 fungicide Substances 0.000 claims description 3
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 2
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 2
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 2
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 2
239000005642 Oleic acid Substances 0.000 claims description 2
235000021314 Palmitic acid Nutrition 0.000 claims description 2
238000013019 agitation Methods 0.000 claims description 2
239000003899 bactericide agent Substances 0.000 claims description 2
VKOBVWXKNCXXDE-UHFFFAOYSA-N ethyl stearic acid Natural products CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 claims description 2
238000010348 incorporation Methods 0.000 claims description 2
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 2
OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 2
235000020778 linoleic acid Nutrition 0.000 claims description 2
WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 2
IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 2
238000005063 solubilization Methods 0.000 claims description 2
230000007928 solubilization Effects 0.000 claims description 2
238000003756 stirring Methods 0.000 claims description 2
239000012873 virucide Substances 0.000 claims description 2
230000005923 long-lasting effect Effects 0.000 claims 2
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims 1
QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims 1
239000000243 solution Substances 0.000 description 11
MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 9
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 8
229940107931 zovirax Drugs 0.000 description 6
229960004150 aciclovir Drugs 0.000 description 4
230000002421 anti-septic effect Effects 0.000 description 3
239000006071 cream Substances 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
210000004400 mucous membrane Anatomy 0.000 description 3
238000012360 testing method Methods 0.000 description 3
241001529453 unidentified herpesvirus Species 0.000 description 3
FOBXOZMHEKILEY-UHFFFAOYSA-N (-)-Aristolene Chemical compound C1C2C(C)(C)C2C2(C)C(C)CCCC2=C1 FOBXOZMHEKILEY-UHFFFAOYSA-N 0.000 description 2
WGTRJVCFDUCKCM-ASEORRQLSA-N Ledene Natural products C[C@@H]1[C@H]2[C@H]3C(C)(C)[C@@H]3CCC(C)=C2CC1 WGTRJVCFDUCKCM-ASEORRQLSA-N 0.000 description 2
CKZXONNJVHXSQM-UHFFFAOYSA-N Ledol Natural products CC(C)C1CCC(C)(O)C2C3CC(C)CC123 CKZXONNJVHXSQM-UHFFFAOYSA-N 0.000 description 2
208000003251 Pruritus Diseases 0.000 description 2
MOYAFQVGZZPNRA-UHFFFAOYSA-N Terpinolene Chemical compound CC(C)=C1CCC(C)=CC1 MOYAFQVGZZPNRA-UHFFFAOYSA-N 0.000 description 2
WGTRJVCFDUCKCM-UHFFFAOYSA-N ent-ledene Natural products C1CC2C(C)(C)C2C2C(C)CCC2=C1C WGTRJVCFDUCKCM-UHFFFAOYSA-N 0.000 description 2
230000007803 itching Effects 0.000 description 2
230000003902 lesion Effects 0.000 description 2
XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
WTEVQBCEXWBHNA-YFHOEESVSA-N neral Chemical compound CC(C)=CCC\C(C)=C/C=O WTEVQBCEXWBHNA-YFHOEESVSA-N 0.000 description 2
WGTRJVCFDUCKCM-FMKGYKFTSA-N viridiflorene Chemical compound C1C[C@H]2C(C)(C)[C@H]2[C@@H]2[C@H](C)CCC2=C1C WGTRJVCFDUCKCM-FMKGYKFTSA-N 0.000 description 2
WGTRJVCFDUCKCM-SCUASFONSA-N viridiflorene Natural products C1C[C@@H]2C(C)(C)[C@H]2[C@@H]2[C@@H](C)CCC2=C1C WGTRJVCFDUCKCM-SCUASFONSA-N 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
206010001488 Aggression Diseases 0.000 description 1
WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
241000700588 Human alphaherpesvirus 1 Species 0.000 description 1
241000701074 Human alphaherpesvirus 2 Species 0.000 description 1
244000011376 Leptospermum laevigatum Species 0.000 description 1
235000017865 Leptospermum laevigatum Nutrition 0.000 description 1
208000008771 Lymphadenopathy Diseases 0.000 description 1
239000004909 Moisturizer Substances 0.000 description 1
208000019802 Sexually transmitted disease Diseases 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
UDMBCSSLTHHNCD-UHTZMRCNSA-N [(2r,3s,4s,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@@H]1O UDMBCSSLTHHNCD-UHTZMRCNSA-N 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000000843 anti-fungal effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229930007050 cineol Natural products 0.000 description 1
229960005233 cineole Drugs 0.000 description 1
WTEVQBCEXWBHNA-JXMROGBWSA-N citral A Natural products CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
229930007927 cymene Natural products 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
YDLBHMSVYMFOMI-SDFJSLCBSA-N germacrene Chemical compound CC(C)[C@H]1CC\C(C)=C\CC\C(C)=C\C1 YDLBHMSVYMFOMI-SDFJSLCBSA-N 0.000 description 1
229930001612 germacrene Natural products 0.000 description 1
230000035876 healing Effects 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
229940087305 limonene Drugs 0.000 description 1
235000001510 limonene Nutrition 0.000 description 1
UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
239000006210 lotion Substances 0.000 description 1
230000001333 moisturizer Effects 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
230000000149 penetrating effect Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
230000000306 recurrent effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000012827 research and development Methods 0.000 description 1
241000894007 species Species 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
230000003253 viricidal effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Virology (AREA)
Medical Informatics (AREA)
Mycology (AREA)
Alternative & Traditional Medicine (AREA)
Botany (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA002524092A 2003-04-28 2004-04-28 Composition et utilisation de l'iode pur dissout dans l'huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia Abandoned CA2524092A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
BE2003/0265A BE1015498A5 (fr)	2003-04-28	2003-04-28	Composition et utilisation de l'iode pur dissout dans l'huile essentielle de melaleuca alternifolia et/ou de melaleuca quinquinervia.
BE2003/0265		2003-04-28
PCT/BE2004/000059 WO2004096248A2 (fr)	2003-04-28	2004-04-28	Composition et utilisation de l’iode pur dissout dans l’huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia

Publications (1)

Publication Number	Publication Date
CA2524092A1 true CA2524092A1 (fr)	2004-11-11

Family

ID=33315071

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002524092A Abandoned CA2524092A1 (fr)	2003-04-28	2004-04-28	Composition et utilisation de l'iode pur dissout dans l'huile essentielle de malaleuca alternifolia et/ou de malaleuca quinquinervia

Country Status (4)

Country	Link
EP (1)	EP1628672A2 (de)
BE (1)	BE1015498A5 (de)
CA (1)	CA2524092A1 (de)
WO (1)	WO2004096248A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1883401B1 (de) *	2005-01-20	2015-11-11	Kayban Pty Ltd.	Antimikrobieller wirkstoff
IL192335A0 (en) *	2008-06-19	2011-08-01	Avivi Easy Life Ltd	Antiviral compounds
ITRE20090011A1 (it) *	2009-02-11	2010-08-12	Gianni Magnanini	Composizione terapeutica per il trattamento dell'herpes labialis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB589097A (en) *	1945-02-15	1947-06-11	Parisepsin Ltd	Improvements in or relating to the manufacture of antiseptic preparations
DD210384A3 (de) *	1982-09-24	1984-06-06	Pharmazeutisches Werk Halle Bo	Verfahren zur herstellung eines medizinischen schwefelbades mit komplexer wirkung
IT1255450B (it) *	1992-06-30	1995-10-31	Montefarmaco Spa	Uso di acidi biliari come agenti antivirali
US6019941A (en) *	1996-01-30	2000-02-01	Porcello; Joseph A.	Method for disinfecting dermal surfaces and inanimate surfaces, and particularly air ducts
US5972362A (en) *	1997-12-23	1999-10-26	Wenker; Naamah T.	Therapeutic skin preparation
RU2150935C1 (ru) *	1999-06-22	2000-06-20	Московский государственный медико-стоматологический университет	Защитно-профилактический крем
AU2001258714A1 (en) *	2000-05-18	2001-11-26	Albert Evdaev	Herbal composition useful for treatment or oral cavity and method for its local delivery thereof
RU2178290C1 (ru) *	2000-11-22	2002-01-20	Московский государственный медико-стоматологический университет	Защитно-профилактический крем
ATE525061T1 (de) *	2001-02-28	2011-10-15	Axiomedic Ltd	Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut

2003
- 2003-04-28 BE BE2003/0265A patent/BE1015498A5/fr not_active IP Right Cessation
2004
- 2004-04-28 WO PCT/BE2004/000059 patent/WO2004096248A2/fr not_active Ceased
- 2004-04-28 EP EP04729797A patent/EP1628672A2/de not_active Withdrawn
- 2004-04-28 CA CA002524092A patent/CA2524092A1/fr not_active Abandoned

Also Published As

Publication number	Publication date
WO2004096248A3 (fr)	2005-01-13
EP1628672A2 (de)	2006-03-01
BE1015498A5 (fr)	2005-05-03
WO2004096248A2 (fr)	2004-11-11

Legal Events

Date	Code	Title	Description
2007-04-30	FZDE	Dead

Publication	Publication Date	Title
CN1113599C (zh)	2003-07-09	单纯性疱疹病毒和其它感染性疾病的抗微生物疗法
US20030007939A1 (en)	2003-01-09	Pharmaceutical compositions and methods for managing dermatological conditions
FR2459661A1 (fr)	1981-01-16	Nouvelle composition medicamenteuse a base de plantes, et procede de preparation
EP0091368A2 (de)	1983-10-12	Mittel zur Bekämpfung von Schmerzen und Unannehmlichkeiten hervorgerufen durch Transpiration
US5888523A (en)	1999-03-30	Topical non-steroidal anti-inflammatory drug composition
US20250221949A1 (en)	2025-07-10	Antiseptic, antiseborrheic, exfoliating composition to remove or prevent acne
EP3878431A1 (de)	2021-09-15	Kosmetische deodorantzusammensetzung, die zink-ricinoleat enthält
JP2023533169A (ja)	2023-08-02	水アルコールゲル及びゲルの製造方法
EP0055635A1 (de)	1982-07-07	Pharmazeutische Zusammensetzung in Gelform, die Acetylsalicylilsäure enthält
US7166281B2 (en)	2007-01-23	Pharmaceutical composition and method for relieving itch, pain and swelling resulting from insect bites and stings
WO1994003186A1 (fr)	1994-02-17	Gel mucoadhesif vaginal, medicament le contenant et procede de preparation dudit gel
WO2011135073A1 (de)	2011-11-03	Adhesive retardformulierungen zur lokalen verabreichung von curcumin
BE1015498A5 (fr)	2005-05-03	Composition et utilisation de l'iode pur dissout dans l'huile essentielle de melaleuca alternifolia et/ou de melaleuca quinquinervia.
EP0851755A1 (de)	1998-07-08	Antiseptische dermatologische zusammensetzung und ein verfahren zu seiner herstellung
RU2074710C1 (ru)	1997-03-10	Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
EP0465313B1 (de)	1994-10-19	Heilende Zusammensetzung zur örtlichen Anwendung
FR2558058A1 (fr)	1985-07-19	Compositions dermatologiques a usage topique externe, a base de metronidazole utiles pour le traitement de l'acne
EP0391780B1 (de)	1993-08-04	Mittel gegen Juckreiz
JP2003055138A (ja)	2003-02-26	プロポリス含有シート状化粧料
FR2745497A1 (fr)	1997-09-05	Composition anti-microbienne, notamment destinee a l'antiseptie et/ou la desinfection
FR2504009A1 (en)	1982-10-22	Topical compsns. contg. arnica extract - together with camphor, menthol and surfactant for topical treatment of inflammations and infections
EP0884948B1 (de)	2001-12-19	Antiseptische zusammensetzungen auf basis von chlorobutanol und chlorhexidin
EP0865289B1 (de)	2002-02-13	Arzneizubereitungen enthaltend arctium majus
FR2793410A1 (fr)	2000-11-17	Utilisation de lipides peroxydes comme agents destines a prevenir et/ou a traiter les effets irritants d'un principe actif
WO2010072923A1 (fr)	2010-07-01	Composition comprenant des saponines